1. 0007 THE OPTIMAL TIME OF DEBULKING SURGERY DIFFERS BETWEEN TAXANE-CONTAINING REGIMEN AND NON-PACLITAXEL REGIMEN IN PATIENTS WITH ADVANCED OVARIAN CANCER. (1st September 2005) Authors: Kuznestov, V.; Kedrova, A.; Gorbunova, V.; Strelstova, O.; Berishvili, A.; Tangomyn, S. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results. (September 2015) Authors: Juhasz, E.; Ramalingam, S.; Blais, N.; Mazieres, J.; Reck, M.; Jones, M.; Urban, L.; Orlov, S.; Barlesi, F.; Kio, E.; Keilholz, U.; Qian, J.; Qin, Q.; Ansell, P.; Dziubinski, J.; Nickner, C.; McKee, M.; Giranda, V.; Gorbunova, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3093 Veliparib with carboplatin and paclitaxel: factors predictive of favorable outcomes in NSCLC. (September 2015) Authors: Reck, M.; Ramalingam, S.; Blais, N.; Mazieres, J.; Jones, M.; Juhasz, E.; Urban, L.; Orlov, S.; Barlesi, F.; Kio, E.; Keilholz, U.; Qian, J.; Qin, Q.; Dziubinski, J.; Nickner, C.; Ansell, P.; McKee, M.; Giranda, V.; Gorbunova, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of eribulin in combination with trastuzumab in HER2-positive metastatic breast cancer patients: Real life experience. (October 2020) Authors: Kovalenko, E.; Manzyuk, L.; Gorbunova, V.; Kolyadina, I.; Bolotina, L.; Zhilyaeva, L.; Ponomarenko, D.; Karabina, E.; Mukhametshina, G.; Khasanova, A.; Ekaterina, R.; Safarova, A.; Manikhas, A.; Volkonsky, M.; Kramskaya, L.; Karandeeva, T.; Suslova, I.; Popova, N.; Evstigneeva, I.; Shumskaya, I. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of eribulin in patients with metastatic breast cancer in early and late application: real life experience. (March 2019) Authors: Filonenko, D.; Gorbunova, V.; Manzyuk, L.; Kovalenko, E.; Zhukova, L.; Bolotina, L.; Kolyadina, I.; Manikhas, A.; Zhilyaeva, L.; Karabina, E. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of eribulin in patients with triple negative metastatic breast cancer: real life experience. (March 2019) Authors: Manikhas, A.; Gorbunova, V.; Manzyuk, L.; Kovalenko, E.; Bolotina, L.; Zhukova, L.; Vladimirova, L.; Kolyadina, I.; Ponomarenko, D.; Mukhametshina, G. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of eribulin in patients with metastatic breast cancer with brain metastases in routine practice in Russian Federation. (March 2019) Authors: Kolyadina, I.; Bulavina, I.; Petkau, V.; Gorbunova, V.; Zhukova, L.; Ganshina, I.; Ponomarenko, D.; Shikina, V.; Popova, N.; Golberg, V. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗